Astrocytes & Amyloid

The relationship between astrocytes and amyloid has been suggested in some neurological diseases such as Alzheimer’s disease. Neuronal damage stimulates the activation of reactive astrocytes, which may the source of amyloid that forms in Alzheimer’s. Here is the latest research on astrocytes and amyloid.

June 17, 2020
Open Access

Impact of TREM2R47H variant on tau pathology-induced gliosis and neurodegeneration

The Journal of Clinical Investigation
Maud GratuzeDavid M Holtzman
May 29, 2020
Review

Neuron-Glia interaction: Molecular basis of Alzheimer's Disease and Applications of Neuroproteomics

The European Journal of Neuroscience
Abdallah Mohammad IbrahimJb Senthil Kumar
July 1, 2020

Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo

Journal of Alzheimer's Disease : JAD
Yingxia LiangCan Zhang
May 28, 2020

A role of low-density lipoprotein receptor-related protein 4 (LRP4) in astrocytic Aβ clearance

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Hongsheng ZhangLin Mei
June 5, 2020
Open Access

A 3D human brain-like tissue model of herpes-induced Alzheimer's disease

Science Advances
Dana M CairnsDavid L Kaplan
May 29, 2020

Neuroprotective effect of quercetin nanoparticles: A possible prophylactic and therapeutic role in alzheimer's disease

Journal of Chemical Neuroanatomy
Rehab Ahmed RifaaiNashwa Fathy Gamal El-Tahawy
June 27, 2020
Open Access

Picornavirus Identified in Alzheimer's Disease Brains: A Pathogenic Path?

JAD Reports
Bo NiklassonElisabet Englund
June 25, 2020
Open Access

ApoE4 Astrocytes Secrete Basement Membranes Rich in Fibronectin and Poor in Laminin Compared to ApoE3 Astrocytes

International Journal of Molecular Sciences
Abby KeableRoxana Octavia Carare
May 30, 2020
Review

Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer's Disease

Cellular and Molecular Neurobiology
Shwetha NanjundaiahSubashchandrabose Chinnathambi

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/astrocytes-amyloid/7301b432-adb0-4f28-afae-1836ce5071f7